The Enhanced Liver Fibrosis (ELF) Test is a noninvasive blood test that measures three direct markers of fibrosis.
Enhanced Liver Fibrosis (ELF) Test
Assess the risk of NAFLD/NASH progression and liver-related events with a simple blood test.
NHS Tayside reduces liver clinic waiting list by 44% with new testing protocols
An extended Intelligent Liver Function (iLFT) pathway has been developed by the University of Dundee and NHS Tayside to improve the diagnosis of liver disease and patient outcomes.
Real-world Evidence and Value
Assessing fibrosis risk with a more accessible blood test can help improve clinical and financial outcomes.
ELF Test indicated as top-performing biomarker in NIMBLE study
Helping to Reshape NASH Clinical Trials
Addressing the rising prevalence of Non-alcoholic Fatty Liver Disease
Learn more about:
Hear from the Experts
Hear from key opinion leaders about the rising prevalence of NAFLD/NASH and the need for non-invasive tests.
Hear from a few Siemens Healthineers colleagues working to help turn the tide against the liver's silent killer – NASH
The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.